Introduction
============

In cardiac myocytes, sympathetic stimulation by β-adrenergic receptors activation is a key regulator of physiological function by controlling heart rate (chronotropic effect), strength of cardiac contraction (inotropic effect), and speed of cardiac relaxation (lusitropic effect, see Bers [@b2] for review). These effects result from activation of the cAMP-dependent protein kinase (PKA) pathway via cAMP production and subsequent phosphorylation of key proteins in the excitation-contraction coupling (ECC) pathway, including the following: (i) L-type Ca^2+^ channels, increasing calcium current; (ii) ryanodine receptors, increasing their sensitivity to trigger Ca^2+^ release; and (iii) the regulatory protein phospholamban, increasing sarcoplasmic reticulum Ca^2+^ uptake via sarcoplasmic reticulum ATPase. The net effect of these changes is to increase the amplitude of the Ca^2+^ transient, thus increasing the strength of contraction (see Bers [@b2] for review).

In the heart, several β-adrenergic receptors are expressed. β~1~-adrenergic receptors play a dominant role in increasing chronotropy and inotropy, whereas β~2~-adrenergic receptors produce only modest chronotorpic effects. A third type of β-adrenergic receptors (β~3~) is also expressed in the heart, but plays a minor functional role in heart (Xiang [@b23]). The concept of spatiotemporal regulation of cAMP and PKA activity is essential for fine tuning of signal transduction, but it is still not clear how the spatial response differs between β~1~- and β~2~-adrenergic receptors. Indeed, adrenergic stimulation induces distinct spatial and temporal responses in ventricular myocytes: β~1~-adrenergic receptor stimulation causes a diffuse cAMP response (global); while β~2~-adrenergic receptors stimulation is locally confined (Xiang [@b23]). Despite being a diffusible small molecule, cAMP diffusion is limited because of degradation by specific phosphodiesterases (Fischmeister et al. [@b11]), which can differentially regulate cAMP production and diffusion by β~1~- and β~2~-adrenergic receptors stimulation, thus cardiac function. In addition, it has been shown that β~2~-adrenergic receptors are also coupled to a G~*i*~-protein that counters the effects of the G~*s*~-protein signalling (Kuschel et al. [@b16]). Finally, the spatial localization of β-adrenergic receptors can play a critical role in the physiological response because of the membrane\'s unique membrane structure, namely the extensive network of t-tubules (large sarcolemmal invaginations at every *Z* lines) essential for synchronizing Ca^2+^ release within the myocyte (Brette and Orchard [@b3]) and the caveolae (small sarcolemmal invaginations discretely distributed along both surface sarcolemma and t-tubules), which are implicated in macromolecular signalling complexes (Harvey and Calaghan [@b12]). Recent compelling studies have shown that caveolae contribute to the compartmentalization of β~2~-adrenergic receptors signal in cardiac myocytes (e.g., Calaghan and White [@b7]). The subcellular distribution of β-adrenergic receptors within ventricular myocytes, and hence their possible role in compartmentalization, has been poorly investigated, particularly at the physiological level. Because the t-tubules are the main site of ECC and underlie synchronous Ca^2+^ release, this subcellular localization is critical in advancing our understanding of ECC modulation.

Biochemical and biophysical characterization have led to conflicting results. Immunohistochemical data have suggested that β~1~- and β~2~-adrenergic receptors are present at the surface membrane and the t-tubules (Zhou et al. [@b25]). Although these studies provide valuable information, quantification of protein distribution (surface sarcolemma vs. t-tubules) from immunostaining data is difficult. Using radioligand binding, it has been determined that β~1~-adrenergic receptors density is almost two times larger in surface sarcolemma than t-tubules (∼65% vs. ∼35% distribution, respectively), whereas β~2~-adrenergic receptors density is evenly distributed between surface sarcolemma and t-tubules (He et al. [@b13]). Other quantitative data have been obtained by the recent advance in live-cell imaging. By combining the smart patch-clamp technique and fluorescence resonance energy transfer (FRET)-based sensor (Epac2-camps to monitor cAMP production), it was found that β~1~-adrenergic receptors are evenly distributed between surface sarcolemma and t-tubules, while β~2~-adrenergic receptors are exclusively located at the t-tubules of ventricular myocytes (Nikolaev et al. [@b17]).

The aim of this study is to address the functional subcellular localization of β~1~- and β~2~-adrenergic receptors using a physiological approach. We have measured changes in Ca^2+^ transient and cell shortening (i.e., physiological functional response in cardiac myocytes) after selective β~1~- and β~2~-adrenergic receptors stimulation in intact rat ventricular myocytes and used acute detubulation, which enables us to determine the functional localization of proteins in ventricular myocytes; surface sarcolemma versus t-tubules (Brette et al. [@b5]; Pasek et al. [@b18]).

Material and Methods
====================

Isolation and detubulation of rat ventricular myocytes
------------------------------------------------------

Myocytes were isolated from ventricles of Wistar rat hearts using a standard enzymatic dissociation protocol (Trafford et al. [@b22]). Detubulation was induced by osmotic shock as described previously (Brette et al. [@b5]). All experiments were performed at room temperature (∼22°C). All procedures were performed in compliance with the UK Home Office Animals (Scientific Procedures) Act 1986.

Solutions
---------

The physiological saline solution (Tyrode solution) contained (in mmol/L): 137 NaCl, 5 KCl, 1 CaCl~2~, 1 MgCl~2~, 10 glucose and 20 HEPES (pH 7.4 with NaOH). To selectively stimulate β~1~-adrenergic receptors, cells were perfused with isoproterenol (ISO, 0.1 μmol/L) and the β~2~-adrenergic receptors antagonist ICI 118,551 (ICI, 0.1 μmol/L). To selectively stimulate β~2~-adrenergic receptors, cells were perfused with salbutamol (10 μmol/L) and the β~1~-adrenergic receptors antagonist atenolol (1 μmol/L) (Calaghan and White [@b7]). All chemicals and drugs were purchased from Sigma (St. Louis, MO).

Recordings of Ca^2+^ transients
-------------------------------

Rat ventricular cells were loaded with the Ca^2^ ^+^ -sensitive fluorescent indicator Fura 2-AM (5 μmol/L; Molecular Probes, Grand Island, NY) for 10 min at room temperature. Cells were electrically field stimulated at 0.33 Hz with a pair of platinum electrodes. The ratio of fluorescence emitted at 510 nm in response to alternate excitation with 340 and 380 nm light was used as an index of intracellular Ca^2+^.

Cell shortening measurements
----------------------------

Myocyte contractions were imaged with a video-edge detection system (Crescent Electronics, Sandy, UT) as previously described (Steadman et al. [@b20]). Cell contraction was induced by electrical field stimulation at 0.33 Hz with a pair of platinum electrodes. Images of cell contraction were captured with a charged-coupled device camera and displayed on a video monitor (Bosch, Frankfurt am Main, Germany).

Data analysis
-------------

Analysis was performed using Clampfit (Molecular Devices, Sunnyvale, CA) and Origin (Microcal, Northampton, MA) software and by averaging 10 signals at steady state.

Statistics
----------

Data are presented as mean ± SEM. Two-way analysis of variance (ANOVA) followed by Tukey post hoc analysis was used to compare data from control and detubulated cells and to test the effect of β-adrenergic stimulation. One-way ANOVA was used to compare the percentage of increase of the amplitude of the Ca^2+^ transient during specific β-adrenergic stimulations between control and detubulated cells. T-tubules value was calculated (see results) therefore no statistical analysis can be performed. *P* \< 0.05 was taken as significant.

Results
=======

To reconcile the conflicting biochemical and biophysical data regarding β~1~- and β~2~-adrenergic receptors distribution in ventricular myocytes, we conducted our experiments in a physiologically relevant system by investigating the effect of specific β agonists in control (i.e., surface sarcolemma and t-tubules stimulation) and detubulated (only surface sarcolemma stimulation) myocytes upon cardiac cell function.

Effect of β~1~-adrenergic stimulation on cardiac function
---------------------------------------------------------

[Figure 1](#fig01){ref-type="fig"}A shows representative Ca^2+^ transients recorded from control (top) and detubulated (bottom) rat ventricular myocytes before (blue and red traces, respectively) and during perfusion with specific β~1~-adrenergic stimulation (0.1 μmol/L ISO and 0.1 μmol/L ICI; cyan and pink traces, respectively). The mean data presented in [Figure 1](#fig01){ref-type="fig"}B show that specific β~1~-adrenergic stimulation induced a large significant increase in the Ca^2+^ transient amplitude in both populations of cells (0.569 ± 0.037 RU \[Ratio Unit\], *n* = 29 control cells vs. 0.227 ± 0.027 RU *n* = 15, detubulated cells, two-way ANOVA, *P* \< 0.05). As previously described (e.g., \[Brette et al. [@b6]\]), in the absence of β~1~-adrenergic stimulation, detubulation significantly reduced the amplitude of the Ca^2+^ transient (0.226 ± 0.024 RU in control cells, vs. 0.069 ± 0.008 RU in detubulated cells, (two-way ANOVA, *P* \< 0.05). In addition, the time to decay to 50% of Ca^2+^ transient was significantly increased after detubulation (two-way ANOVA, *P* \< 0.05, 380 ± 18 msec vs. 835 ± 55 msec, respectively), as previously described (Brette et al. [@b5], [@b6]). Interestingly, application of specific β~1~-adrenergic stimulation caused a significant increase in the Ca^2+^ transient amplitude that appears to be larger in detubulated myocytes, although it does not reach significance (237 ± 43% in control vs. 317 ± 89% in detubulated cells, one-way ANOVA, *P \>* 0.05, [Fig. 1](#fig01){ref-type="fig"}C). This confirms that β-adrenergic stimulation is effective in detubulated myocytes (using ISO only, see \[Brette et al. [@b6]; Smyrnias et al. [@b19]\]). In addition, the time to decay to 50% of Ca transient was significantly decreased after β~1~-adrenergic stimulation in both cell types (two-way ANOVA, *P* \< 0.05, 177 ± 9 msec vs. 444 ± 55 msec, respectively), as previously described (Brette et al. [@b6]).

![Effect of selective β~1~-adrenergic stimulation on Ca^2+^ transient of control and detubulated rat ventricular myocytes. (A) Ca^2+^ transient in representative control (Ctl) and detubulated (Det) myocytes before (bleu and red traces) and after (cyan and pink traces) selective β~1~-adrenergic stimulation. (B) Mean ± SEM of Ca^2+^ transient amplitude under control condition (Tyr) and after β~1~-adrenergic stimulation (β~1~). Data are from 29 control and 15 detubulated cells. (C) Mean ± SEM percentage increase in the Ca^2+^ transient after β~1~-stimulation in control myocytes (surface sarcolemma + t-tubules; SS + TT) and detubulated myocytes (SS, surface sarcolemma). From these values, we have calculated the percentage of increase at the TT (see text for details). \#*P* \< 0.05 between control and detubulated cells; \**P* \< 0.05 between Tyrode and β~1~-adrenergic stimulation.](phy20001-e00038-f1){#fig01}

We calculated the increase in Ca^2+^ transient amplitude at the t-tubules by subtracting the Ca^2+^ transient value from control myocytes (i.e., surface sarcolemma and t-tubules) to detubulated myocytes value (surface sarcolemma only), as previously described (Despa et al. [@b10]; Brette and Orchard [@b4]; Pasek et al. [@b18]). We estimated that the percentage increase in Ca^2+^ transient at the t-tubules membrane was 119%, suggesting that β~1~-adrenergic stimulation is **˜**3 times more affective at surface sarcolemma than at t-tubules ([Table 1](#tbl1){ref-type="table"}). This further indicates a similar role of surface sarcolemma and t-tubules to the increase in Ca^2+^ transient (50% and 50%, [Table 1](#tbl1){ref-type="table"}).

###### 

Distribution of mean (±SEM) ΔCa^2+^ transient and percentage increase during specific β~1~- and β~2~-adrenergic receptors stimulation in surface sarcolemma (SS) and t-tubules (TT)

                                   β~1~-AR stimulation   β~2~-AR stimulation                   
  -------------------------------- --------------------- --------------------- --------------- ---------
  SS + TT (control cells)          0.343 ± 0.013         237 ± 43              0.036 ± 0.010   25 ± 4
  SS (detubulated cells)           0.158 ± 0.019         317 ± 89              0.035 ± 0.004   83 ± 19
  TT (calculated)                  0.185                 119                   0.001           0.8
  \% functional response at TT     54                    50                    2.8             3.2
  Stimulation efficiency (SS/TT)   0.85                  2.66                  35              104

Data are from 29 control and 15 detubulated cells for β~1~-adrenergic receptor stimulation and 41 control and 20 detubulated cells for β~2~-adrenergic receptor stimulation. TT was calculated as \[(SS + TT) − SS\]. See text for details about calculation and quantification.

To demonstrate that the Ca^2+^ transients were representative of cardiac function, we next investigated the effect of β~1~-adrenergic stimulation upon cell shortening. [Figure 2](#fig02){ref-type="fig"}A shows representative traces of cell shortening (expressed as percentage of resting cell length, RCL) in control and detubulated rat ventricular myocytes before (blue and red traces, respectively) and during perfusion with specific β~1~-adrenergic stimulation (cyan and pink traces, respectively). Mean data ([Fig. 2](#fig02){ref-type="fig"}B) show that specific β~1~-adrenergic stimulation induced a significant increase in the amplitude of the cell shortening in both cell types (15.61 ± 0.85% RCL, *n* = 22 control cells vs. 6.76 ± 0.66% RCL *n* = 13, detubulated cells, two-way ANOVA, *P* \< 0.05). Similar to Ca^2+^ transient experiments described above, in the absence of β~1~-adrenergic stimulation, detubulation significantly reduced the amplitude of the cell shortening (6.80 ± 0.81% RCL in control cells vs. 1.61 ± 0.17% RCL in detubulated cells, two-way ANOVA, *P* \< 0.05). The percentage increase in cell shortening induced by specific β~1~- adrenergic stimulation was significantly larger in detubulated cells compared to control myocytes (401 ± 92% in detubulated cells, vs. 196 ± 40% in control cells, one-way ANOVA, *P \<* 0.05, [Fig. 2](#fig02){ref-type="fig"}C). Thus, these data functionally confirm that β~1~-adrenergic receptors are more concentrated at the surface membrane than in t-tubular membrane of rat ventricular myocytes.

![Effect of selective β~1~-adrenergic stimulation on cell shortening of control and detubulated rat ventricular myocytes. (A) Cell shortening in representative control (Ctl) and detubulated (Det) myocytes before (blue and red traces) and after (cyan and pink traces) selective β~1~-adrenergic stimulation. (B) Mean ± SEM of cell shortening expressed as a percentage of resting cell length (RCL) under control condition (Tyr) and after β~1~-adrenergic stimulation (β~1~). Data are from 22 control and 13 detubulated cells. (C) Mean ± SEM of the percentage increase in cell shortening after β~1~-stimulation in control myocytes (surface sarcolemma+t-tubules; SS + TT) and detubulated myocytes (SS, surface sarcolemma). From these values, we have calculated the percentage of increase at the t-tubules (TT, see text for details). \#*P* \< 0.05 between control and detubulated cells; \**P* \< 0.05 between Tyrode and β~1~-adrenergic stimulation.](phy20001-e00038-f2){#fig02}

Effect of β~2~-adrenergic stimulation on cardiac function
---------------------------------------------------------

[Figure 3](#fig03){ref-type="fig"}A shows representative Ca^2+^ transients recorded from control (top) and detubulated (bottom) rat ventricular myocytes before (blue and red traces, respectively) and during perfusion with specific β~2~-adrenergic stimulation (10 μmol/L salbutamol and 1 μmol/L atenolol; cyan and pink traces, respectively). The mean data summarized in [Figure 3](#fig03){ref-type="fig"}B show that specific β~2~-adrenergic stimulation caused a significant increase in the amplitude of the Ca^2+^ transient in both cell types, albeit smaller than β~1~-adrenergic stimulation (0.212 ± 0.014 RU *n* = 41 control cells vs. 0.086 ± 0.009 RU *n* = 20 detubulated cells, two-way ANOVA, *P* \< 0.05), thus confirming that β~1~-adrenergic stimulation is the major β-adrenergic receptor subtype in ventricular myocytes (see Xiang [@b23] for review). In addition, the time to decay to 50% of Ca transient was not significantly changed by β~2~-adrenergic stimulation (382 ± 20 msec vs. 370 ± 22 msec in control cells and 800 ± 56 msec vs. 774 ± 64 msec in detubulated cells, two-way ANOVA, *P \>* 0.05). The percentage increase in Ca^2+^ transient amplitude upon β~2~-adrenergic stimulation was significantly greater in detubulated than in control cells (83 ± 19% vs. 25 ± 4%, respectively, one-way ANOVA, *P* \< 0.05, [Fig. 3](#fig03){ref-type="fig"}C). From these values we calculated the increase in Ca^2+^ transient amplitude at the t-tubules as for β~1~-adrenergic stimulation. We estimated that the percentage increase in Ca^2+^ transient at the t-tubules membrane was only 0.8%, suggesting that β~2~-adrenergic stimulation is almost exclusively due to surface sarcolemma receptors (∼100 times more efficient at surface sarcolemma than at t-tubules, [Table 1](#tbl1){ref-type="table"}). This also indicates that the increase in Ca^2+^ transient is due to 97% by β~2~-adrenergic stimulation at surface sarcolemma and only 3% at t-tubules ([Table 1](#tbl1){ref-type="table"}). Cell shortening was also assessed. [Figure 4](#fig04){ref-type="fig"}A shows representative traces of cell shortening in control and detubulated rat ventricular myocytes before (blue and red traces, respectively) and during perfusion with specific β~2~-adrenergic stimulation (cyan and pink traces, respectively). Mean data are summarized in [Figure 4](#fig04){ref-type="fig"}B and show that specific β~2~-adrenergic stimulation induced a significant increase in the amplitude of the cell shortening in both cell types, although of smaller amplitude than with β~1~-adrenergic stimulation (7.26 ± 0.70% RCL *n* = 23 control cells vs. 2.70 ± 0.82% RCL *n* = 11 detubulated cells, two-way ANOVA, *P* \< 0.05). In agreement with Ca^2+^ transient experiments, quantitative results indicate that cell shortening upon β~2~-adrenergic stimulation was greater in detubulated than in control cells (71 ± 32% vs. 23 ± 5%, respectively, one-way ANOVA, *P* \< 0.05, [Fig. 3](#fig03){ref-type="fig"}C) and that the increase in cell shortening at t-tubules membrane was 0.1%, hence confirming that β~2~-adrenergic stimulation appears to be not functional at the t-tubules. Thus, in agreement with the Ca^2+^ transient experiments, these data confirm that β~2~-adrenergic receptors are only functionally present at the surface sarcolemma of cardiac ventricular myocytes.

![Effect of selective β~2~-adrenergic stimulation on Ca^2+^ transient of control and detubulated rat ventricular myocytes. (A) Ca^2+^ transient in representative control (Ctl) and detubulated (Det) myocytes before (blue and red traces) and after (cyan and pink traces) selective β~2~-adrenergic stimulation. (B) Mean ± SEM of Ca^2+^ transient amplitude under control condition (Tyr) and after β~2~-adrenergic stimulation (β~2~). Data are from 41 control and 20 detubulated cells. (C) Mean ± SEM of the percentage increase in the Ca^2+^ transient after β~2~-stimulation in control myocytes (surface sarcolemma + t-tubules; SS + TT) and detubulated myocytes (SS, surface sarcolemma). From these values, we calculated the percentage of increase at the TT (see text for details). \#*P* \< 0.05 between control and detubulated cells; \**P* \< 0.05 between Tyrode and β~2~-adrenergic stimulation.](phy20001-e00038-f3){#fig03}

![Effect of selective β~2~-adrenergic stimulation on cell shortening of control and detubulated rat ventricular myocytes. (A) Cell shortening in representative control (Ctl) and detubulated (Det) myocytes before (blue and red traces) and after (cyan and pink traces) selective β~2~-adrenergic stimulation. (B) Mean ± SEM of cell shortening expressed as a percentage of resting cell length (RCL) under control condition (Tyr) and after β~2~-adrenergic stimulation (β~2~). Data are from 23 control and 11 detubulated cells. (C) Mean ± SEM of the percentage increase in cell shortening after β~2~-stimulation in control myocytes (surface sarcolemma + t-tubules; SS + TT) and detubulated myocytes (SS, surface sarcolemma). From these values, we have calculated the percentage of increase at the t-tubules (TT, see text for details). \#*P* \< 0.05 between control and detubulated cells; \**P* \< 0.05 between Tyrode and β~2~-adrenergic stimulation.](phy20001-e00038-f4){#fig04}

Discussion
==========

Experimental approach
---------------------

This study provides the first quantification of the functional subcellular localization of the two main cardiac β-adrenergic receptors: β~1~ and β~2~. Previous attempts to determine the localization of those receptors in cardiac myocytes have been mainly performed using immunocytochemistry (see Introduction), yet interpretation and quantification from such experiments can be challenging because antibody binding may depend on epitope accessibility rather than protein distribution itself. In contrast, the detubulation method we applied in this study allows a functional mapping of the proteins within the cell such that it is possible to discriminate the β-adrenergic response between the surface sarcolemma and the t-tubules membrane of ventricular myocytes. This method has been previously validated in cardiac myocytes lacking t-tubules (rat atrial cells) and it was shown to have no effect on proteins function (Brette et al. [@b5]). Importantly, formamide application does not alter β-adrenergic stimulation in rat atrial myocytes (Brette et al. [@b5]), strongly indicating that the experimental approach used in this study does not alter the proteins involved in the β-adrenergic intracellular pathway. Also, we have chosen the concentration of specific β-adrenergic stimulation (β~1~ and β~2~) to be in the mid-range response, based on previous studies (Balijepalli et al. [@b1]; Calaghan and White [@b7]). We believe that the physiological response observed here is more representative than when using maximal concentration of agonists. Thus, in this study, we used Ca^2+^ transient and cell shortening as physiological probes and compared the effects of specific β~1~- and β~2~-adrenergic stimulation in intact ventricular cells and in myocytes depleted from t-tubules (detubulated).

As classically described, the Ca^2+^ transient amplitude was significantly enhanced by adrenergic stimulation, albeit of smaller magnitude with β~2~- compared to β~1~-adrenergic stimulation (Bers [@b2]). We observed a greater response in detubulated myocytes that was irrespective of the type of adrenergic receptors activated. Our mathematical calculation indicates that functional β~1~-adrenergic receptors are more concentrated at the surface sarcolemma than at the t-tubules membrane while functional β~2~-adrenergic receptors are only present at surface sarcolemma of rat ventricular myocytes ([Table 1](#tbl1){ref-type="table"}).

The measure of the change in cell length (an index of contraction) induced by selective β~1~- and β~2~-adrenergic receptor stimulation on intact and detubulated rat ventricular myocytes is in agreement with Ca^2+^ transient measurements. We observed similar qualitative response in control and detubulated myocytes with both β-adrenergic stimulations, that is, β~1~-adrenergic stimulation is more efficient at the surface sarcolemma than at the t-tubules membrane whereas β~2~-adrenergic stimulation is mainly effective at the surface membrane of the cell.

Relation to previous studies
----------------------------

Our functional distribution of β~1~-adrenergic receptors is in agreement with a previous study, which using a biochemical approach (radioligand binding) has shown that β~1~-adrenergic receptors are more abundant at surface sarcolemma than t-tubules (∼2 times) (He et al. [@b13]). However, this slightly contrasts with a study that used a biophysical approach (FRET measurement of cAMP) where it was found that cAMP increased to the same level at surface membrane and t-tubules (Nikolaev et al. [@b17]). It is not obvious why such discrepancy is present. It may be related to the fact that not all cAMP can activate downstream pathway (Steinberg and Brunton [@b21]). In addition, it is well known that observation of pathway activation (cAMP production) is not a reliable indicator of the functional response, for example Ca^2+^ transient (Hohl and Li [@b14]) because of local environment and accessory proteins such as phosphodiesterases and/or A kinase-anchoring proteins (Xiang [@b23]).

The distribution of β~2~-adrenergic receptors is more controversial. Biochemical studies have shown that β~2~-adrenergic receptors (i) have the same abundance at surface sarcolemma and t-tubules, using radioligand binding (He et al. [@b13]), (ii) are expressed at the surface sarcolemma and in the t-tubules of rat ventricular myocytes, using immunostaining (Zhou et al. [@b25]; Smyrnias et al. [@b19]). Our distribution of β~2~-adrenergic receptors reveals that these receptors are only functional at the surface membrane. It is possible that β~2~-adrenergic receptors are present at the t-tubules but not functional (because of local environment, above) or that these receptors are constitutively activated, and able to activate adenylyl cyclase in the absence of agonist (Zhou et al. [@b25]). In support of this hypothesis, Orchard\'s group has shown in two recent studies that there is a tonic PKA activation at the t-tubules (Chase et al. [@b9]; Chase and Orchard [@b8]), strongly suggesting that β~2~-adrenergic receptors are present and functional at the t-tubules and may be constitutively activated. The functional distribution of β~2~-adrenergic receptors contrasts with the results obtained with FRET measurement, where cAMP increased only at t-tubules and not surface sarcolemma during specific β~2~-adrenergic stimulation (Nikolaev et al. [@b17]). It is possible that FRET probe failed to detect the cAMP signal because of inhomogeneous intracellular distribution of the probe within the cytosol (as in the case for the PKA-based FRET probe, e.g*.,* \[Zaccolo and Pozzan [@b24]\]).

Study limitations
-----------------

The experiments were performed at room temperature. Accordingly, we used lower stimulation frequency than in situ (\<1 Hz compare to ∼5 Hz at 37**°**C for rat). We chose these conditions because cell viability and dye loading is prolonged at this temperature. In addition, they match almost all benchmark data used for comparison (e.g., Brette et al. [@b6]; Nikolaev et al. [@b17]; Smyrnias et al. [@b19]).

In this study, we have investigated the end-point of cardiac physiological response (i.e., calcium transient and cell contraction). We did not record intermediate steps of the β-adrenergic intracellular pathway (e.g., L-type Ca^2+^ current). It is possible that the response of L-type Ca^2+^ current would not be representative of the functional effect observed, because in cardiac myocytes, there is no linear relationship between the amplitude of Ca^2+^ current and the Ca^2+^ release by the SR during β-adrenergic stimulation and this observation is true both at the global and local level (Hussain and Orchard [@b15]; Zhou et al. [@b26]). Therefore, it is very possible that, as described for biophysical and biochemical studies (above), intermediate steps in the pathway may respond in a different manner than the physiological response.

Another limitation of this study is that detubulation of myocytes may be incomplete. However, we expect this effect to be small (Despa et al. [@b10]; Pasek et al. [@b18]) and given that the β-adrenergic response (β~1~ and β~2~) is larger in detubulated myocytes than in control, this would underestimate the response at surface sarcolemma and would not change the conclusions of this study.

To conclude, this study provides for the first time a functional mapping of β~1~- and β~2~-adrenergic receptors in rat ventricular myocytes. In addition, this study highlights the importance of using a physiological approach rather than biochemical and/or biophysical approaches when studying signal transduction in cardiac myocytes.
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